TRCT
TIL icon

Tower Research Capital (TRC)’s Instil Bio TIL Stock Holding History

Tower Research Capital (TRC)’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$246 Buy
+32
New +$258 ﹤0.01% 5087
2025
Q4 		– Sell
-3,134
Closed -$56K – 5597
2025
Q3 		$56K Buy
3,134
+2,919
+1,358% +$74.1K ﹤0.01% 2443
2025
Q2 		$4.48K Sell
215
-1,177
-85% -$24.6K ﹤0.01% 4322
2025
Q1 		$24.2K Sell
1,392
-18
-1% -$373 ﹤0.01% 2792
2024
Q4 		$26.9K Buy
1,410
+447
+46% +$13.6K ﹤0.01% 2968
2024
Q3 		$64.8K Buy
963
+892
+1,256% +$21K ﹤0.01% 2570
2024
Q2 		$731 Sell
71
-203
-74% -$2.19K ﹤0.01% 5263
2024
Q1 		$2.96K Sell
274
-48
-15% -$526 ﹤0.01% 4958
2023
Q4 		$2.45K Sell
322
-981
-75% -$7.1K ﹤0.01% 5216
2023
Q3 		$11.2K Sell
1,303
-761
-37% -$7.67K ﹤0.01% 4032
2023
Q2 		$22.7K Buy
2,064
+623
+43% +$7.61K ﹤0.01% 3273
2023
Q1 		$19K Buy
1,441
+496
+52% +$7.33K ﹤0.01% 3511
2022
Q4 		$12K Buy
945
+702
+289% +$34.7K ﹤0.01% 3751
2022
Q3 		$24K Sell
243
-126
-34% -$14.4K ﹤0.01% 3793
2022
Q2 		$34K Buy
369
+313
+559% +$44.3K ﹤0.01% 3258
2022
Q1 		$12K Buy
56
+4
+8% +$935 ﹤0.01% 4099
2021
Q4 		$18K Sell
52
-37
-42% -$14.3K ﹤0.01% 3809
2021
Q3 		$32K Buy
89
+73
+456% +$27.3K ﹤0.01% 3327
2021
Q2 		$6K Sell
16
-147
-90% -$54.5K ﹤0.01% 4643
2021
Q1 		$82K Buy
+163
New +$83.6K ﹤0.01% 2742

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Tower Research Capital (TRC)'s TIL Position: Q2 2026 in Review

Tower Research Capital (TRC) opened a new position in Instil Bio (TIL) in Q2 2026: 32 shares worth $246. The stake represents ﹤0.01% of the portfolio and ranks #5087 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in TIL as recently as Q3 2025.

Tower Research Capital (TRC) first reported a position in TIL in Q1 2021 and has held it in 20 quarters since. The position peaked at $82K in Q1 2021. 26 funds tracked by Wall St. Rank hold TIL as of Q2 2026.

  • Tower Research Capital (TRC) held 32 shares of Instil Bio worth $246 as of Q2 2026.
  • Instil Bio was a new Tower Research Capital (TRC) position in Q2 2026.
  • Instil Bio made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #5087 holding.
  • Tower Research Capital (TRC) first reported a position in Instil Bio in Q1 2021 and has held it in 20 quarters since.
  • Tower Research Capital (TRC)'s Instil Bio position peaked at $82K in Q1 2021.
  • 26 funds tracked by Wall St. Rank held Instil Bio as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.